Euroclear builds on strong momentum in Q3 2025
BRUSSELS, Oct. 24, 2025 /PRNewswire/ -- Results for the first nine months…
Parimatch Sports Joins Baroda Premier League 2025 as Associate Sponsor
Parimatch Sports, a high-quality sportswear brand inspired by top athletes, is proud…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Andamanda Phuket Ranked in Trip Best 2025 Global Top 100 – A Must-Visit for Indian Families
Offering much more than just beaches, Andamanda Phuket — a Thai mythology-inspired water park…
Bybit Bridges the Future of Finance and Music at Tomorrowland Brasil 2025
Bybit Card brings real-world crypto utility to 45,000 festivalgoers at "Portal to…
Huawei Wins Three Awards in the All-Optical Network Field at Network X 2025
PARIS, Oct. 24, 2025 /PRNewswire/ -- At the Network X 2025 ceremony,…
Hisense Ignites Global Football Fever in India with FIFA Club World Cup 2025
Hisense, a global leader in consumer electronics and official partner of the…
“METALEX 2025” Ready to Spotlight Next-Generation Machinery | Driving ASEAN Metalworking Toward Smart Manufacturing
BANGKOK, Oct. 24, 2025 /PRNewswire/ -- METALEX 2025, ASEAN's No.1 Metalworking and…
KuCoin Brings Fresh Brand, Trust-Driven Innovation, and Mining Vision to Dubai’s Blockchain Life 2025
PROVIDENCIALES, Turks and Caicos Islands, Oct. 24, 2025 /PRNewswire/ -- KuCoin, a…
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
October 24, 2025 07:00 ET Â | Source: Sagimet Biosciences Inc. Denifanstat met…